Published in Crit Care Med on December 01, 2012
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Rev Clin Pharmacol (2013) 0.89
New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Subst Abuse Rehabil (2015) 0.84
Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier. Br J Pharmacol (2016) 0.77
Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation. J Cereb Blood Flow Metab (2014) 0.76
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction. Eur J Clin Pharmacol (2016) 0.76
Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: a drug-drug interaction involving p-glycoprotein at the blood-brain barrier? Antimicrob Agents Chemother (2012) 0.75
P-gp/ABCB1 Exerts Differential Impacts On Brain and Fetal Exposure to Norbuprenorphine. Pharmacol Res (2017) 0.75
Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med (2015) 7.02
Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med (2007) 2.80
Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships. Clin Toxicol (Phila) (2010) 2.01
Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med (2008) 1.59
Value of post-resuscitation electrocardiogram in the diagnosis of acute myocardial infarction in out-of-hospital cardiac arrest patients. Resuscitation (2011) 1.48
CNS delivery via adsorptive transcytosis. AAPS J (2008) 1.46
Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med (2002) 1.42
Influence of α-stat and pH-stat blood gas management strategies on cerebral blood flow and oxygenation in patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest: a crossover study. Crit Care Med (2014) 1.41
Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol (2008) 1.41
Should all out-of-hospital cardiac arrest patients presenting with cardiogenic shock be treated with therapeutic hypothermia? Crit Care Med (2013) 1.40
Maintaining lithium elimination is at least as important as early gastrointestinal decontamination in acute-on-chronic poisonings. Clin Toxicol (Phila) (2013) 1.39
Does modulation of organic cation transporters improve pralidoxime activity in an animal model of organophosphate poisoning? Crit Care Med (2011) 1.39
Is early implementation of extracorporeal life support in severely colchicine-poisoned patients lifesaving? Definitive evidence is still lacking. Intensive Care Med (2013) 1.38
Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res (2004) 1.35
Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med (2007) 1.34
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem (2008) 1.32
Deletion of astroglial connexins weakens the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.30
Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm (2011) 1.25
Thallium poisoning: one additional and unexpected risk of heroin abuse. Clin Toxicol (Phila) (2012) 1.21
Effect of chronic exposure to morphine on the rat blood-brain barrier: focus on the P-glycoprotein. J Neurochem (2008) 1.19
Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med (2004) 1.16
Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences. Toxicol Rev (2006) 1.15
Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats. Br J Pharmacol (2003) 1.15
Expression of drug transporters at the blood-brain barrier using an optimized isolated rat brain microvessel strategy. Brain Res (2006) 1.14
Endovascular hypothermia for heat stroke: a case report. Intensive Care Med (2003) 1.12
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res (2007) 1.11
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos (2009) 1.10
Colchicine today. Joint Bone Spine (2006) 1.09
Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care (2007) 1.08
Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier. J Neurochem (2007) 1.08
[Letter on the article "relation between creatinine level and kalaemia in patients with digitalis poisoning"]. Presse Med (2012) 1.07
Why did poisoned patients eventually die long after their ICU stay? Crit Care Med (2015) 1.06
Antidotal treatment of cyanide poisoning. J Chin Med Assoc (2003) 1.06
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). Int J Neuropsychopharmacol (2009) 1.04
Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med (2007) 1.03
The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning. Toxicol Rev (2004) 1.03
The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila) (2012) 1.02
Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem (2003) 1.01
Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar. Pharm Res (2007) 1.01
Validity of leg-to-leg bioelectrical impedance analysis to estimate body fat in obesity. Obes Surg (2011) 1.01
Usefulness of routine laboratory parameters in the decision to treat refractory cardiac arrest with extracorporeal life support. Resuscitation (2011) 0.99
Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia. J Infect Dis (2013) 0.98
Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum (2004) 0.98
Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment. J Subst Abuse Treat (2010) 0.96
Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial. Ann Pharmacother (2005) 0.96
Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine. Mol Pharm (2009) 0.96
Dichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose. J Appl Toxicol (2010) 0.95
Preparation and stability of voriconazole eye drop solution. Antimicrob Agents Chemother (2008) 0.95
Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med (2010) 0.94
Role of ABC transporters in the chemoresistance of human gliomas. Curr Cancer Drug Targets (2006) 0.93
In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier. Pharm Res (2004) 0.92
ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol (2010) 0.92
Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos. Toxicol Sci (2010) 0.92
Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicol Appl Pharmacol (2005) 0.92
Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum. J Appl Toxicol (2009) 0.92
Case 6-2004: severe burns from a nightclub fire. N Engl J Med (2004) 0.91
Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening. J Nucl Med (2011) 0.91
Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats. J Pharmacol Exp Ther (2010) 0.90
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. J Pharmacol Exp Ther (2003) 0.90
Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J Cereb Blood Flow Metab (2011) 0.90
Lithium poisoning: is determination of the red blood cell lithium concentration useful? Clin Toxicol (Phila) (2009) 0.90
Extracorporeal life support in a case of acute carbamazepine poisoning with life-threatening refractory myocardial failure. Intensive Care Med (2006) 0.90
Drug Fever: a descriptive cohort study from the French national pharmacovigilance database. Drug Saf (2012) 0.89
In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain. J Cereb Blood Flow Metab (2008) 0.89
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. J Alzheimers Dis (2012) 0.89
Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier. Curr Drug Metab (2011) 0.89
Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice. Drug Metab Dispos (2008) 0.88
Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2. J Cereb Blood Flow Metab (2012) 0.88
Scorpion envenomation. N Engl J Med (2014) 0.88
Sensory impairment in obese patients? Sensitivity and pain detection thresholds for electrical stimulation after surgery-induced weight loss, and comparison with a nonobese population. Clin J Pain (2013) 0.87
Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology. Curr Pharm Des (2011) 0.87